Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 5Terminated 4Recruiting 4Active not recruiting 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasm Metastasis 25Leukemia, Myeloid, Acute 25Breast Neoplasms 19Prostatic Neoplasms 16Myelodysplastic Syndromes 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 14Lung Neoplasms 13Colorectal Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Burkitt Lymphoma 11Triple Negative Breast Neoplasms 10Neoplasms 9Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Chronic 9Ovarian Neoplasms 8Melanoma 8Stomach Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Myeloproliferative Disorders 6Lymphoma, T-Cell 6Lymphoma, B-Cell 6Carcinoma, Renal Cell 6Mouth Neoplasms 5Lymphoma 5Leukemia, Biphenotypic, Acute 5Fallopian Tube Neoplasms 5

Interventions

Capecitabine 29Oxaliplatin 28Fluorouracil 16Radiotherapy 15Drug Therapy 11Leucovorin 10Bevacizumab 10Surgical Procedures, Operative 9Chemoradiotherapy 8Radiation 7sintilimab 6Consolidation Chemotherapy 6tislelizumab 5spartalizumab 5XELOX 5Specimen Handling 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4Neoadjuvant Therapy 4Endoscopy 4Cetuximab 4Biopsy 4toripalimab 3pembrolizumab 3irinotecan sucrosofate 3X-Rays 3Radiotherapy, Intensity-Modulated 3Proctectomy 3Mastectomy, Segmental 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Rectal Neoplasms × Biopsy × Clear all
NCT07405476 2026-04-17

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

Emory University

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05081024 2025-09-25

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

OHSU Knight Cancer Institute

Recruiting
50 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06780787 2025-06-26

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

City of Hope Medical Center

Phase 2 Recruiting
26 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06266832 2024-02-20

The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma

Sir Run Run Shaw Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡